Bouzas Lorena, Carlos Guinarte J, Carlos Tutor J
Laboratorio Central, Hospital Clínico Universitario, Santiago de Compostela, Spain.
J Clin Lab Anal. 2003;17(6):271-5. doi: 10.1002/jcla.10108.
In the general population, about 5% of individuals are homozygotic and 35% are heterozygotic carriers for chitotriosidase (ChT) deficiency. Activated macrophages are considered to be the main source of plasma ChT activity, which permits the biochemical characterization of homozygote deficients. However, in the case of detecting heterozygotic carriers, the results are often inconclusive. The activities of ChT in plasma and mononuclear (MN) and polymorphonuclear (PMN) leukocytes were determined in 169 control subjects (72 males and 97 females) with a mean age (+/- SD) of 47.5+/-9.7 years (range 18-96 years). The specific enzyme activity was in PMN leukocytes >MN leukocytes >plasma, with a highly significant partial correlation being found between the activities of ChT in plasma and PMN leukocytes (r=0.578, P<0.001). A significant correlation was found between the age of the patients studied and plasma ChT activity (r=0.568, P<0.001). No significant correlation was found for enzyme activities in MN (r=0.105) or in PMN leukocytes (r=0.043). The results obtained suggest that, in normal physiological conditions, PMN leukocytes may secrete ChT to the plasma. Although the activities of ChT in MN and PMN leukocytes are not affected by demographic factors, it is not possible to use them for the biochemical detection of ChT-deficient heterozygotic carriers.
在普通人群中,约5%的个体为壳三糖苷酶(ChT)缺乏症的纯合子,35%为杂合子携带者。活化的巨噬细胞被认为是血浆ChT活性的主要来源,这使得能够对纯合子缺陷者进行生化特征分析。然而,在检测杂合子携带者时,结果往往不明确。对169名对照受试者(72名男性和97名女性)的血浆、单核(MN)和多形核(PMN)白细胞中的ChT活性进行了测定,这些受试者的平均年龄(±标准差)为47.5±9.7岁(范围18 - 96岁)。特异性酶活性在PMN白细胞中>MN白细胞>血浆,血浆和PMN白细胞中的ChT活性之间存在高度显著的部分相关性(r = 0.578,P < 0.001)。研究患者的年龄与血浆ChT活性之间存在显著相关性(r = 0.568,P < 0.001)。在MN(r = 0.105)或PMN白细胞(r = 0.043)中的酶活性未发现显著相关性。所得结果表明,在正常生理条件下,PMN白细胞可能向血浆中分泌ChT。虽然MN和PMN白细胞中的ChT活性不受人口统计学因素影响,但无法用它们对ChT缺乏的杂合子携带者进行生化检测。